SCHEMBL22814739

SCHEMBL22814739

CNC(=O)CNC(=O)C(NC)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
PTGS2 P35354 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ECE1 P42892 1/20 0.35
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
PSMB5 P28074 2/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MME P08473 1/20 0.31
ACE P12821 1/20 0.31
CPA1 P15085 1/20 0.31
ACE2 Q9BYF1 1/20 0.31
MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20756387 1.00 ALDH1A1 (0.35) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL25869803 0.85 PSMB5 (0.36) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL17791875 0.85 ECE1 (0.33) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL22695761 0.82 ALDH1A1 (0.36) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL3338670 0.82 ALDH1A1 (0.55) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL23743699 0.82 ALDH1A1 (0.36) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL29697722 0.82 ALDH1A1 (0.55) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL17305531 0.82 ALDH1A1 (0.55) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL26077042 0.80 ALDH1A1 (0.35) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL25672015 0.80 ALDH1A1 (0.35) ALDH1A1LMNAMAPTPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022108992-A9 PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED PRODRUG FOR SELECTIVE KILLING OF CELLS EXPRESSING PSMA THE JOHNS HOPKINS UNIVERSITY (US) 2023-05-19 WO disclosed
WO-2020254602-A1 CONJUGATES OF AN ELECTRON-DONATING NITROGEN OR TERTIARY AMINE COMPRISING COMPOUNDS ASCENDIS PHARMA A/S (DK) 2020-12-24 WO disclosed
WO-2020254607-A1 ANTI-CTLA4 COMPOUNDS WITH LOCALIZED PD PROPERTIES Ascendis Pharma Oncology Division A/S (DK) 2020-12-24 WO disclosed